The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLIX.l

Myopathy-Myositis-Polymyositis (see also under Xba)

Publications

Kato M, Oiso N, Nozaki Y, Inoue A, Hosono Y, Funauchi M, Mimori T, Matsumura I, Kawada A

Antitumor necrosis factor alpha inhibitor-induced dermatomyositis and interstitial lung disease with anti-PL12 autoantibody: signs of antisynthetase syndrome.

The Journal of dermatology 2014 Nov;41;1034-6 — 2014 Nov — 1034-6

Brunasso AM, Aberer W, Massone C

New onset of dermatomyositis/polymyositis during anti-TNF-? therapies: a systematic literature review.

TheScientificWorldJournal 2014;2014;179180 — 2014 — 179180

Liu SW, Velez NF, Lam C, Femia A, Granter SR, Townsend HB, Vleugels RA

Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis.

JAMA dermatology 2013 Oct;149;1204-8 — 2013 Oct — 1204-8